Altered gut microbiota and systemic immunity in Chinese patients with schizophrenia comorbid with metabolic syndrome
These findings suggested that gut microbiota dysbiosis and immune dysfunction play a vital role in SZ-MetS development, highlighting potential therapeutic approaches targeting the gut microbiota. While these therapies show promise, further mechanistic studies are needed to fully understand their efficacy and safety before clinical implementation.
Authors
- Zongxin Ling (ORCID: https://orcid.org/0000-0001-9662-099X)
- Yiwen Cheng (ORCID: https://orcid.org/0000-0003-3095-9311)
- Jie Gao (ORCID: https://orcid.org/0000-0002-3366-3156)
- Shao Li (ORCID: https://orcid.org/0000-0002-8709-9167)
- Wenhui Lei (ORCID: https://orcid.org/0000-0002-2952-3441)
- Xia Liu (ORCID: https://orcid.org/0000-0002-0180-2166)
- Yuwei Wang (ORCID: https://orcid.org/0000-0002-4630-6975)
- Zhiyong Lan (ORCID: https://orcid.org/0009-0006-6366-6135)
- Wenwen Ding (ORCID: https://orcid.org/0009-0000-3473-588X)
- Zhimeng Li (ORCID: https://orcid.org/0009-0003-6297-8821)
- Rongxian Liao
- Zhangcheng Zhu
- Ying Yu
Institutions
- Shandong University (CN)
- Nantong University (CN)
- Wenzhou Medical University (CN)
- Affiliated Hospital of Nantong University (CN)
- Quzhou City People's Hospital (CN)
- Affiliated Hospital of Hangzhou Normal University (CN)
- Shandong First Medical University (CN)
- State Key Laboratory of Diagnosis and Treatment of Infectious Diseases
- Zhejiang University (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1186/s12967-024-05533-9
- Citations
- 21
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 4.91
Funders
- National Major Science and Technology Projects of China